期刊
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
卷 111, 期 14, 页码 5349-5354出版社
NATL ACAD SCIENCES
DOI: 10.1073/pnas.1317731111
关键词
-
资金
- National Institutes of Health [R01CA154923, R01CA143082, R21CA156056, U54CA168512, K08AR063165, K99CA175184]
- Alex's Lemonade Stand Foundation
- Sarcoma Foundation of America
- Massachusetts General Hospital Howard Goodman Fellowship
- Harvard Stem Cell Institute
- Steward Rahl-Melanoma Research Alliance Young Investigator Award
- American Cancer Society Research Scholar Award
- St. Baldrick's Foundation Scholar Award
- Genomics Institute of the Novartis Research Foundation postdoctoral fellowship
- Massachusetts General Hospital Toteson Fund for Medical Discovery
Embryonal rhabdomyosarcoma (ERMS) is a common pediatric malignancy of muscle, with relapse being the major clinical challenge. Self-renewing tumor-propagating cells (TPCs) drive cancer relapse and are confined to a molecularly definable subset of ERMS cells. To identify drugs that suppress ERMS self-renewal and induce differentiation of TPCs, a large-scale chemical screen was completed. Glycogen synthase kinase 3 (GSK3) inhibitors were identified as potent suppressors of ERMS growth through inhibiting proliferation and inducing terminal differentiation of TPCs into myosin-expressing cells. In support of GSK3 inhibitors functioning through activation of the canonical WNT/beta-catenin pathway, recombinant WNT3A and stabilized beta-catenin also enhanced terminal differentiation of human ERMS cells. Treatment of ERMS-bearing zebrafish with GSK3 inhibitors activated the WNT/beta-catenin pathway, resulting in suppressed ERMS growth, depleted TPCs, and diminished self-renewal capacity in vivo. Activation of the canonical WNT/beta-catenin pathway also significantly reduced self-renewal of human ERMS, indicating a conserved function for this pathway in modulating ERMS self-renewal. In total, we have identified an unconventional tumor suppressive role for the canonical WNT/beta-catenin pathway in regulating self-renewal of ERMS and revealed therapeutic strategies to target differentiation of TPCs in ERMS.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据